Although rates of bacterial STIs have largely stabilized, case counts remain high.
The incidence of bacterial sexually transmitted infections (STIs) climbed sharply during the last decade, with especially high numbers for syphilis (including congenital syphilis). Now, a 2023 CDC surveillance report of case numbers for syphilis (209,253), gonorrhea (601,319), and chlamydia (1,648,568) suggests that the trend may be abating.
Syphilis rates were 1% higher in 2023 than 2022, but cases of primary and secondary syphilis declined by 10%, especially among men who have sex with men. Cases of congenital syphilis continued to rise in number (3882 cases). Gonorrhea rates fell by 8% for the second year in a row, with the largest reduction among women. Chlamydia rates remained flat. In general, however, these STI rates mask stark ethnic…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)